JPH029571B2 - - Google Patents

Info

Publication number
JPH029571B2
JPH029571B2 JP341882A JP341882A JPH029571B2 JP H029571 B2 JPH029571 B2 JP H029571B2 JP 341882 A JP341882 A JP 341882A JP 341882 A JP341882 A JP 341882A JP H029571 B2 JPH029571 B2 JP H029571B2
Authority
JP
Japan
Prior art keywords
formula
dimethylamino
ethoxy
reaction
carvacrol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP341882A
Other languages
Japanese (ja)
Other versions
JPS58121250A (en
Inventor
Teruo Kutsuma
Yasuo Sekine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Inc
Original Assignee
Fujirebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Inc filed Critical Fujirebio Inc
Priority to JP341882A priority Critical patent/JPS58121250A/en
Publication of JPS58121250A publication Critical patent/JPS58121250A/en
Publication of JPH029571B2 publication Critical patent/JPH029571B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】 本発明は下記式() を有する5―〔2―ジメチルアミノ)エトキシ〕
カルバクロールの製法に関する。 本発明は下記式() (上式中Xは塩素、臭素、またはヨウ素を表わ
す)で示される5―〔2―(ジメチルアミノ)エ
トキシ〕―2―ハロ―p―シメンにマグネシウム
を作用させて、一般式 (式中Xは前記と同じ)で示されるグリニヤール
化合物となし、このグリニヤール化合物を、ボラ
ン(水素化ホウ素)と作用させることによつて、
式() (上式中mは0〜2、nは1〜3の整数を表わ
し、m+n=3の関数を有する)で示されるホウ
素誘導体に変換し、次いで過酸化水素で酸化する
ことを特徴とする5―〔2―(ジメチルアミノ)
エトキシ〕カルバクロール(式())の製法に
関する。 5―〔2―(ジメチルアミノ)エトキシ〕カル
バクロール(式())は交換神経抑制作用を有
し、(Arzneim.―Forsch.,17,305(1967)参
照)、さらに循環器系用医薬品として英国薬局方
(British Pharmacopoeia,p455,1980)にも収
載されている下記式() で示される塩酸チモキサミンを合成するための中
間体としても有用な化合物である。 5―〔2―ジメチルアミノ)エトキシ〕カルバ
クロール(式())を製する方法については、
ドイツ特許第905738号、英国特許第745070号、あ
るいはA.Buza et al.,Bull.Soc.Chim.France,
1959,839にすでに報告されている。しかしこれ
らの各文献に記載されている方法は、いずれもチ
モールから6―ニトロソチモールを経由して、7
工程を要して5―〔2―(ジメチルアミノ)エト
キシ〕カルバクロール(式())に導びくもの
である。この方法は、合成の工程数が多く、かつ
第7工程で、ジアゾニウム塩の分解によつてフエ
ノール誘導体(式())に変換する反応で、安
定性に欠ける目的物(式())の著しい着色
(暗褐色)を伴なうため、高純度の目的物(式
())を得ることができないので工業的な製法と
しては、有利な方法ではない。 本発明者らはチモールから2工程で得られる5
―〔2―ジメチルアミノ)エトキシ〕―2―ハロ
―p―シメン(式())を出発原料とし、グリ
ニヤール化合物(式())を経由する簡便な5
―〔2―(ジメチルアミノ)エトキシ〕カルバク
ロール(式())の製造方法を見出した。 すなわち、5―〔2―(ジメチルアミノ)エト
キシ〕―2―ハロ―p―シメン(式())を無
水テトラヒドロフラン中で、当量のマグネシウム
と反応せしめ、対応するグリニヤール化合物(式
())を製造する。この反応液を、ボランのテト
ラヒドロフラン溶液に低温において添加し、ホウ
素誘導体(式())を製する。このホウ素誘導
体を含む反応液に、続いて過酸化水素を当量もし
くはわずかに過剰の量で加えることによつて、水
酸化アルカリに可溶の、5―〔2―ジメチルアミ
ノ)エトキシ〕カルバクロール(式())が高
収率で得られる。 この際、アルカリに不溶の3―〔2―(ジメチ
ルアミノ)エトキシ〕―p―シメン(式())
を副生する。 上記式の化合物の生成は主として、溶媒、試
薬、反応系の環境などに含まれる水分の影響によ
り、グリニヤール化合物(式())から生じた
ものである。 一般にグリニヤール化合物とボランの反応を経
由するフエノール誘導体の合成例は少なく(たと
えばS.W.Breuer,F.A.Broster,J.Organometal.
Chem.,35,C5(1972))、オルトー置換以外のフ
エノール類の収率は60〜70%と報告されている。
当該グリニヤール化合物(式()はオルト―位
にメチル基を、またメタ―位にイソプロピル基を
有し、立体的に比較的障害を受けているにもかか
わらず、フエノール体(式())の収率が70%
以上という好結果が得られる。 ホウ素誘導体を酸化して対応するアルコールま
たはフエノールに転換する反応で、酸化剤とし
て、アルカリの存在下に過酸化水素を使用するの
が一般的な方法である(H.C.Brown,G.
Zweifel,“Organic Reactions”、Vol.13,p22,
John Wiley & Sons,Inc.,New York
(1963))。当該反応においては、特にアルカリを
添加する必要のないことが明らかになつた。さら
にこの酸化反応に用いる過酸化水素の水溶液の濃
度は、10%程度が好ましい。 一般に第3アミンは過酸化水素と反応してN―
オキシドを生成することは、良く知られている事
実である(たとえばJ.Thesing らChem.Ber.,
92,1748(1959);A.C.Cope,E.R.Trumbull,
“Organic Reactions”,Vol.11,p317,John
Wiley & Sons,New York(1960))。本発明
の過酸化水素による酸化反応において、被反応物
(式())および目的物(式())はともに側
鎖に第3アミノ基を有するにもかかわらず、使用
する過酸化水素を10%程度の濃度にした場合に
は、過酸化水素が過剰に反応系に供給されたとし
ても、N―オキシドをほとんど生成しないという
結果が得られた。 ここに得られた目的物(式())は無色また
はわずかに黄色を呈し、冷後固化する高純度の物
質である。さらに副生物(式())は、ハロゲ
ン化することによつて1工程で、本発明の出発原
料(式())に転換し、再利用することができ
ることも本発明の長所の1つである。 本発明において、ハロゲン誘導体(式())
からグリニヤール化合物(式())を経て目的
とするカルバクロール誘導体(式())にいた
る反応は、反応式からみると3工程であるが、反
応操作上からは、これら3工程は、特に反応物を
とり出すことなく、連続して実施されることか
ら、実質的には1工程の反応とみなすことができ
る。 以上述べたように、本発明の方法によれば、従
来の方法に比し、はるかに短い工程で、かつ簡便
な方法で、高純度の5―〔2―(ジメチルアミ
ノ)エトキシ〕カルバクロール(式())を高
収率で取得することができる。 以下に本発明の方法を実施例で示す。 実施例 活性化したマグネシウム0.32g(0.013グラム
原子)および乾燥テトラヒドロフラン8ml中に、
窒素雰囲気下で5―〔2―(ジメチルアミノ)エ
トキシ〕―2―ブロム―p―シメン(式())
3.00g(0.01モル)を乾燥テトラヒドロフラン10
mlにとかした溶液を滴下し、グリニヤール化合物
を製する。この反応液を、氷―食塩系寒剤浴中で
冷却した1M濃度のボラン―テトラヒドロフラン
コンプレツクス溶液10ml(0.01モル)および乾燥
テトラヒドロフラン10mlの混液中に、徐々に滴下
した。滴下終了後、30分間かきまぜをつづけ、こ
の反応液に水5mlを、つづいて10%過酸化水素水
6.8ml(0.02モル)を加えて酸化反応を行なつた。
つづいて過剰の過酸化水素をヨウ化カリウム―チ
オ硫酸ナトリウムを含む水溶液で分解し、3.6%
塩酸5mlを加え、分離した有機層を分取し、水層
をベンゼンで抽出した。両方の有機層を合し、飽
和食塩水で洗浄後、溶媒を留去することによつて
淡黄色の油状物を得た。この油状物を水酸化ナト
リウム1.20g(0.03モル)および水30mlよりなる
水溶液にとかし、少量の不溶物をヘキサンで抽出
した。ヘキサン抽出液を水洗して、硫酸マグネシ
ウムで乾燥した後、濃縮すると、高純度の3―
〔2―(ジメチルアミノ)エトキシ〕―p―シメ
ン(式())を、淡黄色液体として0.54g(収
率24%)の量で得た。一方、アルカリ性水層に炭
酸ガスを導通すると、淡黄色の固型物が析出し
た。これをベンゼンで抽出し、水洗後、硫酸マグ
ネシウムで乾燥し、濃縮すると、5―〔2―(ジ
メチルアミノ)エトキシ〕カルバクロール(式
())を、ほとんど純粋な淡黄色固体として1.74
g(収率73%)の量で得た。酢酸エチルから再結
晶して無色のプリズム晶を得た。 融点 91.6 −92.4℃ 元素分析値 C14H23NOとして C% H% N% 計算値: 70.85 9.77 5.90 実験値: 70.88 9.82 5.84
[Detailed Description of the Invention] The present invention is based on the following formula () 5-[2-dimethylamino)ethoxy]
Regarding the manufacturing method of carvacrol. The present invention is based on the following formula () (wherein X represents chlorine, bromine, or iodine), 5-[2-(dimethylamino)ethoxy]-2-halo-p-cymene is reacted with magnesium, and the general formula By making a Grignard compound represented by the formula (wherein X is the same as above) and reacting this Grignard compound with borane (borohydride),
formula() (In the above formula, m represents an integer of 0 to 2, n represents an integer of 1 to 3, and has a function of m + n = 3), and then oxidized with hydrogen peroxide. -[2-(dimethylamino)
This invention relates to a method for producing [ethoxy]carvacrol (formula ()). 5-[2-(dimethylamino)ethoxy]carvacrol (formula ()) has sympathoinhibitory effects (see Arzneim.-Forsch., 17 , 305 (1967)), and is also used as a drug for the cardiovascular system. The following formula () is also listed in the British Pharmacopoeia (British Pharmacopoeia, p455, 1980). It is also a useful compound as an intermediate for synthesizing thymoxamine hydrochloride shown by Regarding the method for producing 5-[2-dimethylamino)ethoxy]carvacrol (formula ()),
German Patent No. 905738, British Patent No. 745070 or A.Buza et al., Bull.Soc.Chim.France,
Already reported in 1959, 839. However, the methods described in these documents all convert thymol into 7-nitrosothymol via 6-nitrosothymol.
This process leads to 5-[2-(dimethylamino)ethoxy]carvacrol (formula ()). This method involves a large number of synthesis steps, and in the seventh step, the diazonium salt is decomposed to convert it into a phenol derivative (formula ()), resulting in a significant amount of the target product (formula ()) lacking stability. Since it is accompanied by coloration (dark brown), it is not possible to obtain the target product (formula ()) with high purity, so it is not an advantageous method as an industrial production method. We obtained 5 from thymol in two steps.
-[2-dimethylamino)ethoxy]-2-halo-p-cymene (formula ()) is used as a starting material and a simple 5-method via Grignard compound (formula ())
We have discovered a method for producing -[2-(dimethylamino)ethoxy]carvacrol (formula ()). That is, 5-[2-(dimethylamino)ethoxy]-2-halo-p-cymene (formula ()) is reacted with an equivalent amount of magnesium in anhydrous tetrahydrofuran to produce the corresponding Grignard compound (formula ()). do. This reaction solution is added to a solution of borane in tetrahydrofuran at a low temperature to produce a boron derivative (formula ()). By subsequently adding hydrogen peroxide in an equivalent or slightly excess amount to the reaction solution containing this boron derivative, 5-[2-dimethylamino)ethoxy]carvacrol ( Formula ()) is obtained in high yield. At this time, 3-[2-(dimethylamino)ethoxy]-p-cymene (formula ()) insoluble in alkali
as a by-product. The compound of the above formula is produced mainly from the Grignard compound (formula ()) under the influence of water contained in the solvent, reagent, environment of the reaction system, etc. Generally, there are few examples of synthesis of phenol derivatives via the reaction of Grignard compounds and borane (for example, SWBreuer, FABroster, J.Organometal.
Chem., 35 , C5 (1972)), the yield of phenols other than ortho-substituted phenols is reported to be 60-70%.
The Grignard compound (formula ()) has a methyl group at the ortho-position and an isopropyl group at the meta-position, and although it is relatively sterically hindered, the phenolic compound (formula ()) Yield is 70%
The above results are good. A common method for oxidizing boron derivatives to convert them to the corresponding alcohols or phenols is to use hydrogen peroxide in the presence of an alkali as the oxidizing agent (HCBrown, G.
Zweifel, “Organic Reactions”, Vol.13, p22,
John Wiley & Sons, Inc., New York
(1963)). It has become clear that there is no particular need to add an alkali in this reaction. Further, the concentration of the aqueous hydrogen peroxide solution used in this oxidation reaction is preferably about 10%. Generally, tertiary amines react with hydrogen peroxide to form N-
It is a well-known fact that oxides are formed (e.g. J. Thesing et al. Chem. Ber.,
92, 1748 (1959); ACCope, ERTrumbull,
“Organic Reactions”, Vol.11, p317, John
Wiley & Sons, New York (1960)). In the oxidation reaction using hydrogen peroxide of the present invention, although both the reactant (formula ()) and the target object (formula ()) have a tertiary amino group in their side chains, the hydrogen peroxide used is %, even if hydrogen peroxide was supplied in excess to the reaction system, almost no N-oxide was produced. The target product (formula ()) obtained here is a highly pure substance that is colorless or slightly yellow and solidifies after cooling. Furthermore, one of the advantages of the present invention is that the by-product (formula ()) can be converted into the starting material (formula ()) of the present invention in one step by halogenation and reused. be. In the present invention, a halogen derivative (formula ())
From the reaction formula, the reaction leading to the desired carvacrol derivative (formula ()) via the Grignard compound (formula ()) is 3 steps, but from the viewpoint of reaction operation, these 3 steps are particularly important for the reaction. Since the reaction is carried out continuously without taking out the product, it can be substantially regarded as a one-step reaction. As described above, according to the method of the present invention, highly purified 5-[2-(dimethylamino)ethoxy]carvacrol ( Formula ()) can be obtained in high yield. Examples of the method of the present invention are shown below. EXAMPLE In 0.32 g (0.013 gram atom) of activated magnesium and 8 ml of dry tetrahydrofuran,
5-[2-(dimethylamino)ethoxy]-2-bromo-p-cymene (formula ()) under nitrogen atmosphere
3.00g (0.01mol) of dry tetrahydrofuran 10
A Grignard compound is prepared by dropping the solution dissolved in ml. This reaction solution was gradually added dropwise to a mixture of 10 ml (0.01 mol) of a 1M borane-tetrahydrofuran complex solution and 10 ml of dry tetrahydrofuran cooled in an ice-salt cryogen bath. After dropping, continue stirring for 30 minutes, add 5 ml of water to the reaction solution, and then add 10% hydrogen peroxide solution.
An oxidation reaction was carried out by adding 6.8 ml (0.02 mol).
Next, excess hydrogen peroxide was decomposed with an aqueous solution containing potassium iodide-sodium thiosulfate.
5 ml of hydrochloric acid was added, the separated organic layer was separated, and the aqueous layer was extracted with benzene. Both organic layers were combined, washed with saturated brine, and the solvent was distilled off to obtain a pale yellow oil. This oil was dissolved in an aqueous solution consisting of 1.20 g (0.03 mol) of sodium hydroxide and 30 ml of water, and a small amount of insoluble matter was extracted with hexane. The hexane extract is washed with water, dried over magnesium sulfate, and then concentrated to obtain highly pure 3-
[2-(dimethylamino)ethoxy]-p-cymene (formula ()) was obtained as a pale yellow liquid in an amount of 0.54 g (yield 24%). On the other hand, when carbon dioxide gas was passed through the alkaline aqueous layer, a pale yellow solid substance was precipitated. This was extracted with benzene, washed with water, dried over magnesium sulfate, and concentrated to yield 5-[2-(dimethylamino)ethoxy]carvacrol (formula ()) as an almost pure pale yellow solid at 1.74%
g (yield 73%). Recrystallization from ethyl acetate gave colorless prismatic crystals. Melting point 91.6 -92.4℃ Elemental analysis value C 14 H 23 As NO C% H% N% Calculated value: 70.85 9.77 5.90 Experimental value: 70.88 9.82 5.84

Claims (1)

【特許請求の範囲】 1 一般式() (上式中Xは塩素、臭素、またはヨウ素を表わ
す)で示される5―〔2―(ジメチルアミノ)エ
トキシ〕―2―ハロ―p―シメンをマグネシウム
と反応せしめ、一般式() (上式中Xは前記と同じ)で示されるグリニヤー
ル化合物に導き、このグリニヤール化合物とボラ
ンを作用させて、一般式() (上式中mは0〜2、nは1〜3の整数をあらわ
し、m+n=3の関数を有する)で示されるホウ
素誘導体となし、このホウ素誘導体を過酸化水素
で酸化することを特徴とする式() で示される5―〔2―(ジメチルアミノ)エトキ
シ〕カルバクロールの製法。
[Claims] 1 General formula () (In the above formula, X represents chlorine, bromine, or iodine) 5-[2-(dimethylamino)ethoxy]-2-halo-p-cymene is reacted with magnesium, and the general formula () (In the above formula, X is the same as above), and by reacting this Grignard compound with borane, the general formula () (In the above formula, m represents an integer of 0 to 2, n represents an integer of 1 to 3, and has a function of m + n = 3), and this boron derivative is oxidized with hydrogen peroxide. expression () A method for producing 5-[2-(dimethylamino)ethoxy]carvacrol shown by
JP341882A 1982-01-14 1982-01-14 Preparation of 5-(2-(dimethylamino)ethoxy)carvacrol Granted JPS58121250A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP341882A JPS58121250A (en) 1982-01-14 1982-01-14 Preparation of 5-(2-(dimethylamino)ethoxy)carvacrol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP341882A JPS58121250A (en) 1982-01-14 1982-01-14 Preparation of 5-(2-(dimethylamino)ethoxy)carvacrol

Publications (2)

Publication Number Publication Date
JPS58121250A JPS58121250A (en) 1983-07-19
JPH029571B2 true JPH029571B2 (en) 1990-03-02

Family

ID=11556829

Family Applications (1)

Application Number Title Priority Date Filing Date
JP341882A Granted JPS58121250A (en) 1982-01-14 1982-01-14 Preparation of 5-(2-(dimethylamino)ethoxy)carvacrol

Country Status (1)

Country Link
JP (1) JPS58121250A (en)

Also Published As

Publication number Publication date
JPS58121250A (en) 1983-07-19

Similar Documents

Publication Publication Date Title
JPH0251908B2 (en)
JPH029571B2 (en)
CN114181097B (en) Synthesis method of methoxamine hydrochloride
CN101851225A (en) Method for synthesizing fludioxonil intermediate 4-aldehyde-2,2-difluorobenzodioxole
Ichikawa et al. The Reaction of Olefins with Aromatic Substances in the Presence of Mercury Salts and Catalyst. II. Synthesis of β-Arylethyl Alcohols and sym-Diarylethanes
JPH027935B2 (en)
KR930010403B1 (en) (3-vinylphenyl)phenyl methane
GB2065656A (en) Preparing arylpropionic acids
JP2586949B2 (en) Method for producing p- or m-hydroxybenzaldehyde
JPH03112940A (en) Production of (+-)-4-formyl-alpha-alkylbenzyl alcohol
JP5103647B2 (en) Process for producing malonic ester derivative or keto ester derivative and novel compound
JPH027936B2 (en)
US8168833B2 (en) Schwartz reagents: methods of in situ generation and use
JPS625137B2 (en)
JPH01121229A (en) Production of alkylphenol
Bachmann The Reduction of Azobenzene, Azoxybenzene and Nitrosobenzene by the System Magnesium+ Magnesium iodide
JPS6159615B2 (en)
JPS62120334A (en) Synthesis of catechol compound
US862674A (en) Process of making ortho-dioxyphenylethanolethylamin.
JP3831975B2 (en) Method for producing pyrogallol
FR2515646A1 (en) NEW PROCESS FOR THE PREPARATION OF 4- (3-METHYL-2-BUTENYL) -1,2-DIPHENYL-3,5-DIOXOPYRAZOLIDINE
JPH08295647A (en) Production of fluorenone
JPH0327338A (en) Production of bis(2-hydroxyhexafluoro-2-propyl)-benzene derivative
JPH0211565A (en) Preparation of metachloroperbenzoic acid
JPS6239141B2 (en)